Factors Influencing the Use of Thoracic Radiotherapy in Lung Cancer—an Analysis of the 1995 Scottish Lung Cancer Audit
- 1 June 2002
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 14 (3) , 219-227
- https://doi.org/10.1053/clon.2001.0046
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based studyThorax, 2001
- Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective studyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- EUROCARE-2: relevance for assessment of quality of cancer services?The Lancet, 2000
- Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete RemissionNew England Journal of Medicine, 1999
- Variation in survival of patients with lung cancer in Europe, 1985–1989European Journal Of Cancer, 1998
- The Effect of Radiotherapy on the Survival of Non-Small Cell Lung Cancer PatientsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trialThe Lancet, 1997
- Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance statusClinical Oncology, 1996
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung CancerNew England Journal of Medicine, 1992
- A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance statusBritish Journal of Cancer, 1992